Difference between revisions of "Team:BostonU"

 
(96 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
{{Team:BostonU}}
 
{{Team:BostonU}}
−
 
 
<html>
 
<html>
−
<head>
+
<header>
−
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
+
<title>Home</title>
−
<title>Boston University IGEM 2015</title>
+
−
 
+
 
<style type="text/css">
 
<style type="text/css">
−
   
+
/*
−
* {
+
−
margin: 0px; padding: 0px;
+
−
}
+
−
.clear {
+
−
clear:both;}
+
−
.clearleft {
+
−
display:block;
+
−
clear:left;}
+
−
.clearright{
+
−
display:block;
+
−
clear:right;}
+
−
.hide {
+
−
display:none;}
+
−
a {
+
−
color:#B32C0E;
+
−
}
+
−
 
+
−
a:hover {
+
−
color:#000000;
+
−
text-decoration:none;
+
−
}
+
−
body {
+
−
background: #FFFFFF  url(images/bg.jpg) repeat-x;
+
−
}
+
−
#wrap {
+
−
    width: 100%;
+
−
    margin: 0px auto 15px auto;
+
−
    font-family: Verdana, Arial, Helvetica, sans-serif;
+
−
    font-size: 12px;
+
−
    color: #666666;
+
−
}
+
−
 
+
−
/*Header*/
+
−
 
+
 
#header {
 
#header {
−
+
  margin-top: 150px;
 
     height: 265px;
 
     height: 265px;
−
     background: url(homepic.jpg) no-repeat;
+
     background: url(https://static.igem.org/mediawiki/2015/0/08/Homepic.JPG) no-repeat;
 
     background-repeat: no-repeat;
 
     background-repeat: no-repeat;
 
     background-position: center;  
 
     background-position: center;  
 
}
 
}
−
/*Header Menu*/
+
#contentpage {
−
#topmenu {
+
−
    display: block;
+
−
    list-style: none;
+
−
    padding: 0 0px 0px 0px;
+
−
}
+
−
#topmenu li {
+
−
display:inline;
+
−
}
+
−
#topmenu a {
+
−
    display: block;
+
−
    float: left;
+
−
    height: 28px;
+
−
    margin: 0px 0px 0px 0px;
+
−
    text-decoration: none;
+
−
    padding: 9px 15px 0px 15px;
+
−
    text-align: center;
+
−
    font-family: calibri;
+
−
    font-size: 15px;
+
−
    font-weight: bold;
+
−
}
+
−
#topmenu a, #topmenu a:visited, #topmenu a:active {
+
−
color:#FFFFFF;
+
−
}
+
−
#topmenu a:hover{
+
−
color:#ffffff;
+
−
background-color: #B52E10;
+
−
}
+
−
#topmenu .active a, #topmenu .active a:visited, #topmenu .active a:active{
+
−
color:#FFFFFF;
+
−
background-color: #B42D0F;
+
−
}
+
−
 
+
−
/*Content*/
+
−
#content {
+
 
     border-color: #C0C0C0;
 
     border-color: #C0C0C0;
−
     background-color: #FFFFFF;
+
     background-color: #DBDBFF;
 
     width: 80%;
 
     width: 80%;
 
     margin-right: auto;
 
     margin-right: auto;
Line 99: Line 28:
 
     padding: 10px;
 
     padding: 10px;
 
     height: 300px;
 
     height: 300px;
 +
    margin-right: auto;
 +
    margin-left: auto;
 
     box-shadow: 5px 5px 2px #888888;
 
     box-shadow: 5px 5px 2px #888888;
 
     border-radius: 10px;
 
     border-radius: 10px;
−
     background-color: #F0F0F0;
+
     background-color: #DBDBFF;
−
     font-family: 'Calibri Light';
+
     font-family: Arial, Helvetica, sans-serif;
 
}
 
}
 
#mainpage p {
 
#mainpage p {
Line 109: Line 40:
 
}
 
}
 
#mainpage blockquote {
 
#mainpage blockquote {
−
background:#efefef;
+
background:#DBDBFF;
 
display:block;  
 
display:block;  
 
margin:5px;
 
margin:5px;
−
font:Georgia, "Times New Roman", Times, serif;  
+
font family: Arial, Helvetica, sans-serif;
−
font-style:italic;}
+
        font-style:italic;
−
h2, h3, h4, h5 {
+
}
−
     color: #B32C0E;
+
h2, h4, h5 {
 +
     color: #000000;
 
     font-weight: bold;
 
     font-weight: bold;
 
     font-family: Arial, Helvetica, sans-serif;
 
     font-family: Arial, Helvetica, sans-serif;
Line 121: Line 53:
 
     font-size: 30px;
 
     font-size: 30px;
 
}
 
}
−
h1 {
+
.clear {
−
    color: #B32C0E;
+
clear:both;}
−
    font-weight: bold;
+
−
    font-family: Calibri;
+
−
    height: 59px;
+
−
    vertical-align: middle;
+
−
    line-height: 60px;
+
−
    font-size: 30px;
+
−
    width: 962px;
+
−
    float: left;
+
−
}
+
−
 
+
−
 
+
−
#mainpage h1 {
+
−
font-size:24px;
+
−
color: #F2F7F3;
+
−
}
+
−
#mainpage h2 {
+
−
font-size:20px;
+
−
padding-top: 20px;
+
−
padding-bottom: 5px;
+
−
border-bottom: 1px solid #B52E10;
+
−
}
+
−
#mainpage h3 {
+
−
font-size:20px;}
+
−
#mainpage h4 {
+
−
font-size:18px;}
+
−
#mainpage h5 {
+
−
font-size:16px;}
+
−
.style_2 {
+
−
font-size: 7px;
+
−
color: #000011;
+
−
}
+
−
.style_2 a{
+
−
font-size: 7px;
+
−
color: #000011;
+
−
}
+
−
.style_2 a:hover{
+
−
font-size: 7px;
+
−
color: #000011;
+
−
}
+
−
#content #mainpage ol {
+
−
margin:10px 10px 10px 25px;}
+
−
#content #mainpage ol li {
+
−
padding:5px 5px 5px 20px;}
+
−
#content #mainpage ul li {
+
−
display:block;
+
−
padding:0px;
+
−
border-bottom: dashed 1px #D6E4A7;}
+
−
 
+
−
 
+
−
 
+
−
 
+
−
/*Sidebar*/
+
−
#sidebar {
+
−
margin:0px 0px 0px 0px;
+
−
width: 225px;
+
−
float: right;
+
−
}
+
−
#sidebarcontents {
+
−
padding:5px 0px 5px 0px;
+
−
}
+
−
 
+
−
/*Sidemenu*/
+
−
#menu {
+
−
list-style:none;
+
−
}
+
−
#menu li ul {list-style:none;}
+
−
#menu li ul li {
+
−
display:block;
+
−
height:25px;
+
−
border-bottom:solid 1px #efefef;}
+
−
#menu li ul a, #menu li ul a:visited, #menu li ul a:active {
+
−
display:block;
+
−
height:20px;
+
−
padding:5px 5px 0px 5px;
+
−
text-decoration:none;
+
−
color:#333333;}
+
−
#menu li ul  a:hover {
+
−
background:#F8F9F2;
+
−
color:#B32C0E;
+
−
}
+
−
#menu h2 {
+
−
display:block;
+
−
border-bottom:solid 1px #D2E6CA;
+
−
padding:5px;
+
−
margin:10px 0px 0px 0px;
+
−
font-family: Arial, Helvetica, sans-serif;
+
−
font-size:18px;
+
−
color:#B32C0E;
+
−
font-weight:bold;
+
−
}
+
−
 
+
−
/*footer*/
+
−
#footer {
+
−
    margin: 20px auto 0 auto;
+
−
    width: 98.2%;
+
−
    height: 60px;
+
−
    padding: 10px;
+
−
    color: #FFFFFF;
+
−
    text-align: center;
+
−
    background: #333333;
+
−
    font-family: Verdana, Arial, Helvetica, sans-serif;
+
−
    font-size: 11px;
+
−
    clear: both;
+
−
}
+
−
#credit {font-size:10px;
+
−
padding:3px;}
+
−
#sitename a {
+
−
    text-decoration: none;
+
−
 
+
−
    vertical-align: middle;
+
−
    float: left;
+
−
    height: 41px;
+
−
}
+
−
#topbar {
+
−
    height: 116px;
+
−
    background-color: #333333;
+
−
}
+
−
#caption{
+
−
height:50px;
+
−
background:url(images/caption.gif) repeat-x top left;
+
−
}
+
−
.bold{font-size:16px;
+
−
color:#FFFFFF;
+
−
padding-left:100px;
+
−
padding-top:25px;
+
−
}
+
−
.headername {
+
−
    padding: 10px;
+
−
    height: 58px;
+
−
    vertical-align: middle;
+
−
    background-color: #FFFFFF;
+
−
    color: #800000;
+
−
}
+
−
.headericon {
+
−
    float: left;
+
−
    width: 90px;
+
−
    height: 60px;
+
−
}
+
−
.igemicon {
+
−
    float: right;
+
−
    width: 100px;
+
−
    height: 60px;
+
−
    margin-right: 15px;
+
−
}
+
  
 +
*/
 
  </style>
 
  </style>
−
   
+
</header>
 +
<body bgcolor="#DBDBFF">
 +
<div id="wrapper">
  
−
</head>
+
<div id="header">
 +
</div>
  
−
<body>
 
  
−
<div id="wrap">
+
<div id="contentpage">
−
<div id="topbar">
+
<div id="mainpage">
−
    <div class="headername">
+
<h2 style="font-color:#000000; margin-left:50px;">Developing conditionally dimerizable split protein systems for genetic logic and genome editing applications </h2>
−
        <div class="headericon">
+
−
            <img src="headericon.png" style="height: 61px; width: 87px" alt="headericon" />
+
−
        </div>
+
−
  <h1 id="sitename"><a href="https://2015.igem.org/Team:BostonU/Home">Boston University IGEM 2015  </a></h1>
+
  
−
          <div class="igemicon">
+
<p style="padding-bottom:50px;">The field of synthetic biology seeks to engineer desirable cellular functionalities by developing molecular technologies that enable precise genetic manipulation. A promising solution is to reliably control proteins that naturally execute genetic modifications. Current strategies to regulate activity of such proteins primarily rely on modulating protein expression level through transcriptional control; however, these methods are susceptible to slow response and leaky expression. In contrast, strategies that exploit post-translational regulation of activity, such as conditional dimerization of split protein halves, have been demonstrated to bypass these limitations. Here, we compare the relative efficiency of previously characterized dimerization domains in regulating activities of three important genetic manipulation proteins - integrases and recombination directionality factors for genetic logic applications, and saCas9 for in vivo genome editing applications. We also establish guidelines to rationally identify promising protein split sites. Our characterization of these systems in mammalian cells ultimately paves way for important biomedical applications.</p>
−
            <img src="Igemlogo_banner.jpg" style="height: 62px; width: 101px" alt="headericon" />
+
−
        </div>
+
−
  </div>
+
  
−
  <div id="menus">
+
<center>
−
  <ul id="topmenu">
+
<table align="center">
−
            <li class="active"><a href="https://2015.igem.org/Team:BostonU/Home">Home</a></li>
+
<tr>
−
<li><a href="https://2015.igem.org/Team:BostonU/Team">Team</a></li>
+
<td><center><a href="https://2015.igem.org/Team:BostonU/Temporal_Control"><img style="height:85%; width:85%;" src="https://static.igem.org/mediawiki/2015/thumb/9/99/Active_and_inactive_protein.png/800px-Active_and_inactive_protein.png" /></a><center></td>
−
<li><a href="https://2015.igem.org/Team:BostonU/Project">Project</a></li>
+
<td><center><a href="https://2015.igem.org/Team:BostonU/App_1/Motivation"><img style="height:85%; width:85%; padding-left:30px; padding-right:30px;" src="https://static.igem.org/mediawiki/2015/thumb/8/86/Home_page_integrase_RDF.png/562px-Home_page_integrase_RDF.png" /></a></center></td>
−
<li><a href="https://2015.igem.org/Team:BostonU/Notebook">Notebook</a></li>
+
<td><center><a href="https://2015.igem.org/Team:BostonU/App_2/Motivation"><img style="height:60%; width:60%;" src="https://static.igem.org/mediawiki/2015/thumb/1/1c/Crispr_cas9_labeled.png/800px-Crispr_cas9_labeled.png" /></a></center></td>
−
<li><a href="https://2015.igem.org/Team:BostonU/Attributions">Attributions</a></li>
+
</tr>
−
<li><a href="https://2015.igem.org/Team:BostonU/Collaborations">Collaborations</a></li>
+
−
<li><a href="https://2015.igem.org/Team:BostonU/Practices">Human Practices</a></li>
+
−
<li><a href="https://2015.igem.org/Team:BostonU/Safety">Safety</a></li>
+
−
<li><a href="https://2015.igem.org/Team:BostonU/Modeling">Modeling</a></li>
+
−
<li><a href="https://2015.igem.org/Team:BostonU/Measurement">Measurement</a></li>
+
−
<li><a href="https://2015.igem.org/Team:BostonU/Software">Software</a></li>
+
−
<li><a href="https://2015.igem.org/Team:BostonU/Entrepreneurship">Entrepreneurship</a></li>
+
−
</ul>
+
−
</div>
+
−
</div>
+
  
−
<div id="header">
+
<tr>
−
</div>
+
<td><h3 align="center" style="padding-bottom:50px;">Controlling Protein Activity</h3></td>
−
    <br />
+
<td><h3 align="center" style="padding-bottom:50px;">Controlling Integrases and RDFs</h3></td>
 +
<td><h3 align="center" style="padding-bottom:50px;">Controlling saCas9</h3></td>
  
−
<div id="content">
+
</tr>
−
<div id="mainpage">
+
−
<h2>Welcome to Our Project !</h2>
+
−
<p>
+
−
    The goal of our team this summer is to create an efficient and widely applicable workflow for splitting proteins. By splitting proteins and fusing each half to a drug-inducible domain, scientists can gain temporal control over protein expression. Using our workflow, the proteins will be translated into two inert halves that are each fused to domains that bind in the presence of an inducer drug. By introducing the drug into the system, the two inert protein halves will come together and for a fully functioning protein. In this way, scientists can further increase their control over protein function. The two types of proteins we will be testing our workflow on are the large serine integrase family and saCAS9. These proteins harness powerful mechanisms that have significant applications in the future of synthetic biology. By using our workflow, we hope to increase scientists understanding of these proteins and also provide a mechanism for increasing temporal control.
+
−
</p>
+
−
</div>
+
  
 +
<tr>
 +
<td><center><a href="https://2015.igem.org/Team:BostonU/Mammalian_synbio/Significance"><img style="height:50%; width:50%;" src="https://static.igem.org/mediawiki/2015/thumb/5/59/Mammalian_syn_bio_home_page.png/618px-Mammalian_syn_bio_home_page.png" /></a></center></td>
 +
<td><center><a align="center" href="https://2015.igem.org/Team:BostonU/Education/Building_with_Biology"><img style="height:95%; width:95%; padding-left:30px; padding-right:30px;" src="https://static.igem.org/mediawiki/2015/c/c5/Building_w_biology.jpg" /></a></center></td>
 +
<td><center><a href="https://2015.igem.org/Team:BostonU/Attributions"><img style="height:200px; width:200px;" src="https://static.igem.org/mediawiki/2015/3/39/Thank_you_attributions.png"/></a></center></td>
 
</div>
 
</div>
−
    <br />
+
</tr>
−
    <br />
+
−
    <br />
+
−
<div class="clear"></div>
+
−
    <div class="clear"></div>
+
  
−
<div id="footer">
+
<tr>
−
<p>Copyright Boston Unversity IGEM &copy; 2015  <a href="#"></a></p>
+
<td><h3 align="center">Mammalian Synthetic Biology</h3></td>
−
    <div>
+
<td><h3 align="center">Education and Outreach</h3></td>
−
        <br />
+
<td><h3 align="center">Attributions</h3></td>
−
<div>
+
</tr>
−
<a href="[full link to your Twitter]">
+
</table>
−
<img title="Twitter" alt="Twitter" src="https://socialmediawidgets.files.wordpress.com/2014/03/twitter.png" width="35" height="35" />
+
<br><br><br><br><br><br><br><br>
−
</a>
+
<h4 style="font-size:25px; text-align:center;">iGEM Jamboree 2015 Results</h4>
−
<a href="[full link to your Facebook page]">
+
<ol style="font-size:23px;text-align:center">Medal Received: Gold.<br>Nominated for Best Foundational Advance Project</li>
−
<img title="Facebook" alt="Facebook" src="https://socialmediawidgets.files.wordpress.com/2014/03/facebook.png" width="35" height="35" />
+
−
</a>
+
−
<a href="mailto:[email address]">
+
−
<img title="Email" alt="Email" src="https://socialmediawidgets.files.wordpress.com/2014/03/email.png" width="35" height="35" />
+
−
</a>
+
  
−
</div>
 
−
 
−
    </div>
 
−
</div>
 
−
</div>
 
  
  
 +
<br><br><br>
  
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 20:30, 3 October 2015

Home

Developing conditionally dimerizable split protein systems for genetic logic and genome editing applications

The field of synthetic biology seeks to engineer desirable cellular functionalities by developing molecular technologies that enable precise genetic manipulation. A promising solution is to reliably control proteins that naturally execute genetic modifications. Current strategies to regulate activity of such proteins primarily rely on modulating protein expression level through transcriptional control; however, these methods are susceptible to slow response and leaky expression. In contrast, strategies that exploit post-translational regulation of activity, such as conditional dimerization of split protein halves, have been demonstrated to bypass these limitations. Here, we compare the relative efficiency of previously characterized dimerization domains in regulating activities of three important genetic manipulation proteins - integrases and recombination directionality factors for genetic logic applications, and saCas9 for in vivo genome editing applications. We also establish guidelines to rationally identify promising protein split sites. Our characterization of these systems in mammalian cells ultimately paves way for important biomedical applications.

Controlling Protein Activity

Controlling Integrases and RDFs

Controlling saCas9

Mammalian Synthetic Biology

Education and Outreach

Attributions








iGEM Jamboree 2015 Results

    Medal Received: Gold.
    Nominated for Best Foundational Advance Project